Financial Performance - Net revenue for Q4 2025 was $252.5 million, a decrease of 2.0%, while full-year revenue reached $946.4 million, an increase of 2.8% compared to the previous year[5] - Gross profit for Q4 2025 was $70.2 million, up 2.1%, and for the full year, it was $258.6 million, reflecting a growth of 7.6% year-over-year[5] - Operating income for Q4 2025 was $11.8 million, a significant improvement of 115.4%, while the full-year operating loss narrowed to $(6.3) million, a 93.9% improvement[5] - Adjusted operating income for Q4 2025 was $12.8 million, and for the first time, the full year reached break-even at $0.1 million[5] - Free cash flow was positive at $10.2 million for Q4 2025 and $18.0 million for the full year, more than doubling the previous year's record[5] - Net revenue for the year ended December 31, 2025, increased by 6.0% to $330,242,000 compared to $311,689,000 in 2024[16] - Gross profit for the same period rose by 9.2% to $86,053,000, with a gross margin improvement to 26.1% from 25.3%[16] - Operating income for the year reached $30,332,000, a significant increase of 1841.2% compared to a loss of $1,742,000 in 2024[16] - Cannabis retail operations generated a total revenue of $406.8 million for the full year, reflecting an 11.4% increase compared to the previous year[12] Cash and Assets - The company had $252.2 million in unrestricted cash and no debt as of December 31, 2025, positioning it well for future investments[6] - As of December 31, 2025, the company held $649.9 million in unrestricted cash and marketable securities, with no outstanding debt[22] - Cash and cash equivalents increased from CAD 218,359 thousand at the beginning of the period to CAD 252,243 thousand at the end of the period, an increase of 15.5%[29] - Total assets decreased from CAD 1,349,242 thousand in 2024 to CAD 1,335,917 thousand in 2025, a decline of approximately 1.0%[28] Investments and Acquisitions - The acquisition of five Cost Cannabis retail stores was completed on January 6, 2026, with ongoing regulatory approval for an additional 27 stores in Ontario[11] - The acquisition of five "Cost Cannabis" stores was completed, enhancing market presence in Alberta and Saskatchewan[16] Restructuring and Operational Efficiency - The company achieved over $20 million in annualized savings from its corporate restructuring program, expected to conclude in Q2 2026[11] - The restructuring process for Skymint and Parallel is ongoing, with expected updates in Q3 2026[22] - The company experienced a significant reduction in share-based compensation expenses from CAD 20,037 thousand in 2024 to CAD 13,905 thousand in 2025, a decrease of approximately 30.5%[29] - Restructuring costs increased to $3,337,000 for the year, compared to $2,667,000 in 2024, suggesting ongoing adjustments in operational strategy[41] Shareholder Information - The company repurchased 15,055,627 common shares since Q4 2024, with the latest purchases at an average price of $1.64 per share[22] - Shareholders' equity decreased from CAD 1,133,356 thousand in 2024 to CAD 1,101,196 thousand in 2025, a decline of about 2.8%[28] Performance Metrics - Same store sales metrics are utilized to evaluate retail performance, excluding the impact of new store openings and closures[38] - The company reported a gross margin that reflects its ability to manage input costs and pricing strategies effectively[35] - Adjusted EBITDA for Q4 2025 was $23,748,000, slightly up from $23,725,000 in Q4 2024, indicating stable operational performance[41] - The company continues to utilize adjusted EBITDA as a key performance metric to evaluate operational results, excluding non-recurring items and other adjustments[40] Loss and Expenses - Net loss for the period improved from CAD 96,204 thousand in 2024 to CAD 15,774 thousand in 2025, representing a reduction of about 83.6%[29] - Other net expenses for the year totaled $9,425,000, up from $1,798,000 in 2024, reflecting increased operational costs[41] - Non-recurring items for the year resulted in a net loss of $621,000, contrasting with a gain of $882,000 in 2024, indicating increased one-time expenses[41] - The share of loss from equity-accounted investees was $3,605,000 for the year, compared to a gain of $65,459,000 in 2024, highlighting a significant shift in investment performance[41]

Core Insights - SNDL Inc. reported record financial performance for the full year 2025, with net revenue reaching CAD 946.4 million, a growth of 2.8% compared to the previous year, driven by strong growth in the Cannabis business [5][30] - The company achieved new records in gross profit and gross margin, with gross profit of CAD 258.6 million for the full year, reflecting a 7.6% increase year-over-year [5][30] - Positive cash flow was reported, with CAD 33.9 million for the full year, and free cash flow more than doubled from the previous year to CAD 18.0 million [5][30] Financial Performance - Net revenue for Q4 2025 was CAD 252.5 million, a decrease of 2.0% compared to Q4 2024, while full-year revenue was CAD 946.4 million [5][8] - Gross profit for Q4 2025 was CAD 70.2 million, up 2.1% year-over-year, and CAD 258.6 million for the full year, up 7.6% [5][30] - Operating income for Q4 2025 was CAD 11.8 million, a significant improvement from a loss of CAD 76.1 million in Q4 2024 [5][30] Business Segments - The Cannabis Retail segment achieved net revenue of CAD 330.2 million for the full year, a 6.0% increase from the previous year, while the Cannabis Operations segment reported a 32.1% increase in revenue to CAD 144.7 million [11][21] - Liquor Retail revenue declined by 2.8% for the full year to CAD 539.6 million, with same-store sales down 2.3% [15][16] - The company operates 192 cannabis retail locations and 167 liquor retail locations as of March 2026 [14][16] Strategic Initiatives - SNDL is advancing its restructuring efforts in the U.S. cannabis market, particularly with its investments in Parallel and Skymint [6][26] - The company has increased capital expenditures to CAD 12.8 million in 2025, focusing on new store openings [6] - SNDL has repurchased 4.3 million common shares since December 2025, totaling 15.1 million shares repurchased since Q4 2024 [12][26] Cash Position and Investments - As of December 31, 2025, SNDL had CAD 252.2 million in unrestricted cash and no debt, positioning the company for future growth opportunities [7][26] - The investment portfolio generated CAD 4.2 million in operating income for the full year, primarily from interest earned [26] - The company has a carrying value of CAD 397.6 million in cannabis-related investments, with ongoing restructuring processes for its investments in Skymint and Parallel [26]

Industry Overview - The cannabis industry is experiencing significant expansion, with increasing collaboration among businesses to create innovative products and a growing global demand for cannabis [1][2] - Despite market challenges, investors are optimistic about the long-term profitability of cannabis stocks, particularly in the US, Canada, Europe, and other global markets [2] Market Outlook - The year 2026 is projected to be a promising time for shareholders in the cannabis sector, with expectations of higher trading levels [3] - The success of pot stocks does not guarantee better trading conditions, indicating that various factors influence the sector's trading performance [3] Company Highlights - **Cronos Group Inc.**: Engages in the cultivation, production, distribution, and marketing of cannabis products internationally [4] - **Aurora Cannabis Inc.**: Reported a 47% year-over-year increase in net revenue for Q4 2025, reaching $44.5 million, and a 25% increase for FY 2025, totaling $146.6 million. The company has an industry-leading balance sheet with $832 million in cash and equivalents [7][9] - **SNDL Inc.**: Focuses on the production, distribution, and sale of cannabis products for the adult-use market in Canada. The company is set to report its Q4 2025 earnings on March 12, 2026 [9][11]

Core Insights - Marijuana stocks present diverse investment opportunities despite their volatility, with multi-state operators (MSOs) and companies directly involved with cannabis capturing significant market share [1][2] - Ancillary companies providing services and products to cannabis producers are also emerging as viable investment options, indicating a broadening landscape for legal cannabis investments [2] - Positive speculation surrounds the future of legal cannabis, prompting investors to seek promising marijuana stocks for potential substantial returns [3] Company Highlights - **Aurora Cannabis Inc.**: Engages in the production, distribution, and sale of cannabis products in Canada and internationally. The company will participate in TD Cowen's 46th Annual Health Care Conference on March 2, 2026 [4][7] - **SNDL Inc.**: Focuses on the production and sale of cannabis products for the adult-use market in Canada. The company is set to report its Q4 2025 and full-year results on March 12, 2026, followed by a conference call [8][11] - **Organigram Global Inc.**: Involved in the production and sale of cannabis products in Canada. The company announced the launch of medical vapes and pastilles in Australia, marking a significant step in its international expansion [11][12]

Core Viewpoint - SNDL Inc. is set to release its fourth quarter and full year 2025 financial results on March 12, 2026, before market opening [1] Company Overview - SNDL Inc. is one of the largest vertically integrated cannabis companies in Canada and the largest private-sector liquor and cannabis retailer [2] - The company operates retail banners including Ace Liquor, Wine and Beyond, Liquor Depot, Value Buds, and Spiritleaf [2] - SNDL's consumer-facing cannabis brands include Top Leaf, Contraband, Palmetto, Bon Jak, La Plogue, Versus, Value Buds, Grasslands, Vacay, Pearls by Grön, No Future, and Bhang Chocolate [2] - The company aims to deploy strategic capital through direct and indirect investments and partnerships in the North American cannabis industry [2]

Core Insights - SNDL Inc. has experienced a steady decline in share prices over the past six months, primarily due to increasing competition in Canada's cannabis market rather than company-specific issues [1][10] - The company's lack of direct operations in the U.S. has limited its ability to capitalize on recent cannabis policy changes, leading to diminished investor interest compared to U.S.-focused operators [2][10] Company Fundamentals - SNDL operates through four segments: Liquor Retail, Cannabis Retail, Cannabis Operations, and Investments, with its Cannabis Retail segment being one of the largest in Canada, operating approximately 186 locations as of November 3, 2025 [4] - Cannabis sales increased by 16% year-over-year over the first nine months of 2025, indicating strong performance despite a competitive landscape [5] - For the first time in its history, SNDL generated positive cumulative free cash flow in the first nine months of the year, alongside consistent same-store sales growth in cannabis retail [6] Expansion and Acquisitions - The company is expanding its retail presence through acquisitions, including the recent purchase of five cannabis retail stores from 1CM in Alberta and Saskatchewan, which is expected to enhance financial performance [7] - SNDL is pursuing the acquisition of an additional 27 stores from 1CM, pending regulatory approvals [7] Competitive Landscape - SNDL faces intense competition from companies like Curaleaf Holdings and Tilray Brands, which are expanding into international markets, providing them with additional growth opportunities [8] - The lack of U.S. operations makes SNDL more vulnerable to pricing pressures and market saturation in Canada, negatively impacting investor sentiment [9] Stock Performance - SNDL's stock has declined by 31% over the past six months, while cannabis sales rose by 16% during the same period [10] - Year-to-date, SNDL shares have lost 19%, compared to a 16% decline in the broader industry [11]

Industry Overview - The cannabis industry is undergoing significant changes with new laws and regulations that support its development [1][2] - Investors are focusing on companies that demonstrate strong performance or are working towards substantial goals, which can lead to profitability [1] Investment Opportunities - In 2026, there is anticipation for a new marijuana stock run, with potential breakout opportunities for various cannabis stocks [2][3] - It is crucial for investors to prepare for the volatility inherent in the cannabis sector [2] Key Companies to Watch - **Tilray Brands, Inc.**: Engages in the research, cultivation, processing, and distribution of medical cannabis products across multiple regions including Canada, the US, and Europe [4] - Recently appointed Romano Beverage to enhance distribution in Illinois, indicating a strategic move to accelerate growth [5][6] - **Cronos Group Inc.**: Focuses on the cultivation, production, distribution, and marketing of cannabis products internationally [8] - Launched its Lord Jones® premium cannabis brand in Israel, highlighting its strategy to penetrate key markets [9][10] - **SNDL Inc.**: Involved in the production and distribution of cannabis products for the adult-use market in Canada [10] - Announced a share repurchase program authorizing the repurchase of up to C$100 million of its outstanding common shares, indicating confidence in its stock value [12][13]

Group 1: Company Overview - SNDL Inc. operates in the Canadian adult-use cannabis market with a diversified business model that includes Liquor Retail, Cannabis Retail, Cannabis Operations, and Investments, allowing it to balance performance across segments [1] - The company is involved in the production, distribution, and sale of cannabis products, providing exposure to multiple parts of the value chain [1] Group 2: Recent Acquisitions - On January 8, SNDL completed the acquisition of five 1CM cannabis retail locations in Alberta and Saskatchewan, marking the first closing under its amended agreement with 1CM Inc. [2] - This acquisition is part of a larger plan to add 27 Ontario-based stores, which are pending regulatory approvals [2] - An amended agreement with 1CM Inc. was announced on December 15, 2025, to acquire 32 cannabis retail stores for a total cash consideration of $32.2 million, structured into two closings to meet regulatory requirements [3] Group 3: Financial Performance - In Q3 2025, SNDL reported a record quarterly free cash flow of $16.7 million and a positive cumulative free cash flow of $7.7 million for the first nine months of the year [4] - Net revenue increased by 3.1% year over year to $244 million, driven by strength in the Cannabis segment, which helped offset challenges in the Liquor Retail business [4] - These results indicate improving cash generation and resilience despite broader market headwinds [4]

Core Insights - President Trump's executive order to reschedule cannabis to Schedule 3 is considered a significant shift in federal cannabis policy, potentially alleviating the burdensome tax regime affecting U.S. cannabis operators for decades [1][2]. Tax Implications - The executive order could lead to the elimination of Section 280E of the Internal Revenue Code, which currently taxes legal cannabis operators as if they were narcotics traffickers, preventing them from deducting any business expenses [2][3]. - Rescheduling cannabis to Schedule 3 would allow U.S. companies to deduct standard operating costs, significantly improving their financial health and cash flow [3]. Market Reaction - The cannabis industry is responding positively to the news, especially after a strong performance in 2025, where the AdvisorShares MSOS ETF outperformed the S&P 500 [4]. - Despite the optimistic outlook, the sector is still viewed as highly volatile, with many institutional investors remaining cautious due to past political inaction [4]. Remaining Challenges - Even with the potential rescheduling, U.S. cannabis companies still face hurdles, such as the inability to list on major exchanges like NASDAQ or NYSE, which is available to Canadian companies [5]. - The industry is also awaiting "safe harbor" provisions for banking, which remain unresolved [5]. Stock Performance - Recent performance data for cannabis stocks and ETFs shows varied results, with AdvisorShares Pure U.S. Cannabis ETF (NYSE:MSOS) leading with a 68.55% increase over six months, while other companies like Tilray Brands Inc. (NASDAQ:TLRY) and Canopy Growth Corp. (NASDAQ:CGC) show mixed performance [7].

Industry Overview - The cannabis sector is experiencing growth despite historical volatility, with expectations for significant developments by 2026 that could benefit shareholders [1][2] - Recent legislative changes in the U.S., including the reversal of the 2018 farm bill and an executive order to reschedule cannabis, have sparked speculation about the future profitability for legal operators [2] Company Highlights - **Cronos Group Inc.**: Engages in the cultivation, production, distribution, and marketing of cannabis products internationally. Recently entered the Netherlands market by acquiring CanAdelaar B.V., the largest cannabis company in the Netherlands, which is seen as a strategic move to expand its footprint in Europe [3][4][5] - **Aurora Cannabis Inc.**: Focuses on the production and distribution of cannabis products. The company has made significant advancements in disease resistance research, moving from research to production trials of cultivars with verified PM2 resistance [6][7][8] - **SNDL Inc.**: Engages in the production and sale of cannabis products for the adult-use market in Canada. Recently received approval for a share repurchase program, allowing the company to repurchase up to C$100 million of its outstanding common shares [9][10]